BNP Paribas Financial Markets
WVE icon

BNP Paribas Financial Markets’s Wave Life Sciences WVE Stock Holding History

BNP Paribas Financial Markets’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.04M Buy
281,023
+199,001
+243% +$2.59M ﹤0.01% 2648
2025
Q4 		$1.39M Buy
82,022
+58,400
+247% +$593K ﹤0.01% 2884
2025
Q3 		$173K Sell
23,622
-48,837
-67% -$395K ﹤0.01% 4073
2025
Q2 		$471K Sell
72,459
-161,194
-69% -$1.06M ﹤0.01% 3360
2025
Q1 		$1.89M Buy
233,653
+90,811
+64% +$993K ﹤0.01% 2400
2024
Q4 		$1.77M Buy
142,842
+101,014
+241% +$1.35M ﹤0.01% 2441
2024
Q3 		$343K Buy
41,828
+34,588
+478% +$207K ﹤0.01% 3018
2024
Q2 		$36.1K Sell
7,240
-34,226
-83% -$195K ﹤0.01% 3530
2024
Q1 		$256K Buy
41,466
+232
+0.6% +$1.16K ﹤0.01% 3175
2023
Q4 		$208K Buy
41,234
+30,858
+297% +$165K ﹤0.01% 3195
2023
Q3 		$59.7K Sell
10,376
-5,024
-33% -$22.9K ﹤0.01% 3431
2023
Q2 		$56.1K Buy
15,400
+14,711
+2,135% +$59.4K ﹤0.01% 3434
2023
Q1 		$2.98K Buy
689
+124
+22% +$568 ﹤0.01% 3615
2022
Q4 		$3.96K Sell
565
-579
-51% -$2.67K ﹤0.01% 3684
2022
Q3 		$4.13K Sell
1,144
-19,633
-94% -$65K ﹤0.01% 4271
2022
Q2 		$67.5K Buy
20,777
+17,047
+457% +$32.8K ﹤0.01% 3480
2022
Q1 		$7.46K Sell
3,730
-6,208
-62% -$15.2K ﹤0.01% 3830
2021
Q4 		$31.2K Buy
9,938
+2,542
+34% +$10.6K ﹤0.01% 3809
2021
Q3 		$36.2K Buy
7,396
+5,591
+310% +$33.9K ﹤0.01% 3580
2021
Q2 		$12K Sell
1,805
-2,389
-57% -$15.6K ﹤0.01% 3678
2021
Q1 		$23.5K Sell
4,194
-1,913
-31% -$18.4K ﹤0.01% 3728
2020
Q4 		$48.1K Buy
6,107
+477
+8% +$4K ﹤0.01% 3571
2020
Q3 		$47.8K Buy
5,630
+4,884
+655% +$53.5K ﹤0.01% 3487
2020
Q2 		$7.77K Sell
746
-6,243
-89% -$58.7K ﹤0.01% 3816
2020
Q1 		$65.5K Buy
6,989
+4,336
+163% +$36.9K ﹤0.01% 3422
2019
Q4 		$21.3K Sell
2,653
-676
-20% -$16.6K ﹤0.01% 3987
2019
Q3 		$68.3K Buy
3,329
+1,067
+47% +$24.5K ﹤0.01% 3325
2019
Q2 		$59K Sell
2,262
-1,948
-46% -$54.6K ﹤0.01% 3322
2019
Q1 		$164K Buy
4,210
+4,206
+105,150% +$171K ﹤0.01% 2813
2018
Q4 		$168 Sell
4
-547
-99% -$24.3K ﹤0.01% 4120
2018
Q3 		$27.6K Hold
551
– – ﹤0.01% 3288
2018
Q2 		$21.1K Sell
551
-1,968
-78% -$84.7K ﹤0.01% 3475
2018
Q1 		$101K Buy
2,519
+66
+3% +$2.77K ﹤0.01% 3173
2017
Q4 		$86.1K Buy
2,453
+1,246
+103% +$36.3K ﹤0.01% 3380
2017
Q3 		$26.3K Sell
1,207
-77
-6% -$1.55K ﹤0.01% 3455
2017
Q2 		$23.9K Buy
1,284
+1,256
+4,486% +$27.1K ﹤0.01% 3566
2017
Q1 		$770 Sell
28
-416
-94% -$11.6K ﹤0.01% 3753
2016
Q4 		$11.6K Sell
444
-108
-20% -$3.51K ﹤0.01% 3386
2016
Q3 		$17.9K Buy
552
+260
+89% +$6.14K ﹤0.01% 2954
2016
Q2 		$6.04K Buy
+292
New +$4.55K ﹤0.01% 3179

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BNP Paribas Financial Markets's WVE Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Wave Life Sciences (WVE) stake by 243% in Q1 2026, buying an estimated $2.59M and bringing the position to 281,023 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2648.

BNP Paribas Financial Markets first reported a position in WVE in Q2 2016 and has held it in 40 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • BNP Paribas Financial Markets held 281,023 shares of Wave Life Sciences worth $2.04M as of Q1 2026.
  • BNP Paribas Financial Markets bought 199,001 Wave Life Sciences shares in Q1 2026, an estimated $2.59M.
  • Wave Life Sciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #2648 holding.
  • BNP Paribas Financial Markets first reported a position in Wave Life Sciences in Q2 2016 and has held it in 40 quarters since.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.